MoneyWorks4Me

An increase of about 181.97% to Rs. 422.44 millions in the total revenue was observed for the quarter ended March 2023. The total revenue was pegged at Rs. 149.82 millions during the similar quarter previous year.The Total Profit for the quarter ended March 2023 of Rs. 53.71 millions grew from Rs.-9.50 millionsOP of the company witnessed a marginal growth to 78.78 millions from 8.51 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 422.44 149.82 181.97 1153.50 851.40 35.48 1153.50 851.40 35.48
Other Income 2.59 12.31 -78.96 32.73 16.98 92.76 32.73 16.98 92.76
PBIDT 78.78 8.51 825.73 189.90 136.60 39.02 189.90 136.60 39.02
Interest 7.04 2.09 236.84 20.38 7.94 156.68 20.38 7.94 156.68
PBDT 71.74 4.51 1490.69 169.52 107.10 58.28 169.52 107.10 58.28
Depreciation 15.25 14.01 8.85 53.34 54.93 -2.89 53.34 54.93 -2.89
PBT 56.49 -9.50 -694.63 116.18 52.17 122.70 116.18 52.17 122.70
TAX 2.78 0.00 0.00 2.78 0.00 0.00 2.78 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 53.71 -9.50 -665.37 113.40 52.17 117.37 113.40 52.17 117.37
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) 18.65 5.68 228.31 16.46 16.04 2.61 16.46 16.04 2.61
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..